Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bayer Aktienges ADR (OP: BAYRY )

7.270 +0.010 (+0.14%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,852,602
Open 7.390
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 7.260
Today's Range 7.230 - 7.390
52wk Range 6.960 - 16.81
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Nasdaq, Inc. (NASDAQ: NDAQ) is 
Via Benzinga
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
Unlock AI-powered radiology solutions with Bayer AG and Google Cloud collaboration. Accelerate medical imaging innovations with gen AI tools for faster diagnoses. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-22.49%
-22.49%
1 Month
-0.27%
-0.27%
3 Month
-18.22%
-18.22%
6 Month
-32.43%
-32.43%
1 Year
-55.86%
-55.86%

More News

Read More
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
Via Benzinga
Topics Bonds
Exposures Debt Markets
Bayer-Backed Boundless Bio Falls After IPO
Via Talk Markets
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
Via AB Newswire
Topics Supply Chain
Exposures Supply Chain
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Via Benzinga
Exposures Product Safety
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Glyphosate Legal
BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
Via Benzinga
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
Via InvestorPlace
What's Going On With BridgeBio Pharma Stock On Monday?
Via Benzinga
Exposures Product Safety
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
Via Investor's Business Daily
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
Via InvestorPlace
3 Overextended Stocks That Need to Slash Their Dividends ASAP
Via InvestorPlace
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Via Talk Markets
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
Via Talk Markets
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
Via Benzinga
Topics Lawsuit
Exposures Financial Glyphosate Legal
Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
Via Benzinga
Exposures Glyphosate
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week
Via Talk Markets
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Via Benzinga
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
Via Benzinga
Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
Via Benzinga
Top Stocks, Sectors Loved By Congress Members Who Traded In 2023: Apple, NVIDIA, Microsoft, Ford And More Stocks To Watch In 2024
Via Benzinga
Best 4 Agriculture Companies For Your 2024 Investment Portfolio
Via Talk Markets
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
Via Benzinga
Topics Lawsuit
Exposures Financial Glyphosate Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.